MARKET

VCNX

VCNX

Vaccinex Inc
NASDAQ
0.6220
-0.0180
-2.81%
After Hours: 0.5847 -0.0373 -6.00% 19:10 02/08 EST
OPEN
0.5800
PREV CLOSE
0.6400
HIGH
0.6300
LOW
0.5437
VOLUME
1.67M
TURNOVER
0
52 WEEK HIGH
2.280
52 WEEK LOW
0.4100
MARKET CAP
26.57M
P/E (TTM)
-1.2278
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 22h ago
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
Benzinga · 23h ago
Why Is Rubius Therapeutics (RUBY) Stock Down 16% Today?
Investor Place · 1d ago
Why Is Bed Bath & Beyond (BBBY) Stock Down 32% Today?
Investor Place · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 1d ago
Why Is Vaccinex (VCNX) Stock Up 67% Today?
Investor Place · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Investor Place · 1d ago
Vaccinex Granted U.S. Patent #11572408: Treatment Of Cancer With A Semaphorin-4D Antibody In Combination With An Epigenetic Modulating Agent
Benzinga · 2d ago
More
About VCNX
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab (VX15/2503), is a humanized monoclonal antibody that binds and blocks the signaling activity of semaphorin 4D (SEMA4D). It is focused on the development of pepinemab for the treatment of certain cancer indications, in particular, head and neck squamous cell carcinoma (HNSCC) as well as neurodegenerative diseases, including Huntington's disease (HD), and Alzheimer's disease, (AD). The Company has discovered VX5 using its ActivMAb antibody discovery platform. VX5 is a human antibody to CXCL13, a molecule that regulates the formation of immune tissues, and is in preclinical development for the treatment of multiple sclerosis (MS) and for other autoimmune disorders.

Webull offers kinds of Vaccinex Inc stock information, including NASDAQ:VCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCNX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VCNX stock methods without spending real money on the virtual paper trading platform.